HLPVSPACB• 12 Months (Normalized)
HLP vs PACB (Hongli Group Inc. vs Pacific Biosciences of California Inc.)
Showing Closing Date Range from Oct 6, 2025 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HLP Performance $2.47
+77.7%
Hongli Group Inc.
Normalized Baseline0.00%
PACB Performance $2.87
+88.82%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
Alpha Spread Margin PACB LEADS
-11.12 pts
PACB outperforming by 11.12 percentage points
HLPPACB
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HLP PACB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | HLP Price | HLP Gain (%) | PACB Price | PACB Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $2.47 | +77.70% | $2.87 | +88.82% | -11.12% |
| Oct 02, 2026 | $2.55 | +83.45% | $2.54 | +67.11% | +16.34% |
| Oct 01, 2026 | $- | $2.51 | +65.13% | - | |
| Sep 30, 2026 | $- | $2.37 | +55.92% | - | |
| Sep 29, 2026 | $- | $1.83 | +20.39% | - | |
| Sep 28, 2026 | $2.39 | +71.94% | $1.71 | +12.50% | +59.44% |
| Sep 25, 2026 | $2.21 | +58.99% | $- | - | |
| Sep 24, 2026 | $2.20 | +58.27% | $1.46 | -4.28% | +62.55% |
| Sep 23, 2026 | $2.04 | +46.40% | $1.41 | -7.24% | +53.64% |
| Sep 22, 2026 | $2.00 | +43.88% | $- | - | |
| Sep 21, 2026 | $2.03 | +46.04% | $1.36 | -10.53% | +56.57% |
| Sep 18, 2026 | $2.02 | +45.32% | $1.37 | -9.87% | +55.19% |
| Sep 17, 2026 | $2.02 | +45.32% | $1.38 | -9.21% | +54.53% |
| Sep 16, 2026 | $2.07 | +48.92% | $1.34 | -11.84% | +60.76% |
| Sep 15, 2026 | $1.82 | +30.94% | $1.34 | -11.84% | +42.78% |
Page 1 of 17